Transoral resection for squamous cell carcinoma of the base of the tongue

Archives of Otolaryngology - Head and Neck Surgery

Volumn 135, Issue 12, 2009, Pages 1231-1238

  Henstrom, Douglas K ^a   Moore, Eric J ^a   Olsen, Kerry D ^a   Kasperbauer, Jan L ^a   McGree, Michaela E ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; DISTANT METASTASIS; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; FUNCTIONAL STATUS; GLOSSECTOMY; HUMAN; HYPOTHYROIDISM; LENGTH OF STAY; LUNG EMBOLISM; LYMPH NODE METASTASIS; LYMPHEDEMA; MALE; MEDICAL RECORD REVIEW; MORBIDITY; MOUTH DISEASE; MULTIMODALITY CANCER THERAPY; NECK DISSECTION; ODYNOPHAGIA; OTALGIA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; RETROSPECTIVE STUDY; SPEECH; SQUAMOUS CELL CARCINOMA; SURGICAL APPROACH; SURVIVAL RATE; SWALLOWING; TASTE DISORDER; TERTIARY HEALTH CARE; TONGUE CARCINOMA; TRACHEOSTOMY; TREATMENT OUTCOME; TRISMUS; TUBE REMOVAL; WOUND CARE; XEROSTOMIA;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; ENTERAL NUTRITION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL RATE; TONGUE NEOPLASMS;

EID: 73949083855     PISSN: 08864470     EISSN: 08864470     Source Type: Journal    
DOI: 10.1001/archoto.2009.177     Document Type: Article

References (33)

1. Fein DA, Lee WR, Amos WR, et al. Oropharyngeal carcinoma treated with radiotherapy: a 30-year experience. Int J Radiat Oncol Biol Phys. 1996;34(2):289-296.
2. Hinerman RW, Parsons JT, Mendenhall WM, Stringer SP, Cassisi NJ, Million RR. External beam irradiation alone or combined with neck dissection for base of tongue carcinoma: an alternative to primary surgery. Laryngoscope. 1994;104(12):1466-1470.
3. Barrs DM, Desanto LW, O'Fallon WM. Squamous cell carcinoma of the tonsil and tongue base region. Arch Otolaryngol. 1979;105(8):479-485.
4. Cosmidis A, Rame JP, Dassonville O, et al; Groupement d'Etudes des Tumeurs de la Tête et du Cou (GETTEC). T1-T2 N0 oropharyngeal cancers treated with surgery alone: a GETTEC study. Eur Arch Otorhinolaryngol. 2004;261(5):276-281.
5. Riley RW, Fee WE Jr, Goffinet D, Cox R, Goode RL. Squamous cell carcinoma of the base of the tongue. Otolaryngol Head Neck Surg. 1983;91(2):143-150.
6. Schleuning AJ II, Summers GW. Carcinoma of the tongue: review of 220 cases. Laryngoscope. 1972;82(8):1446-1454.
7. Strong EW. Carcinoma of the tongue. Otolaryngol Clin North Am. 1979;12(1):107-114.
8. Weber RS, Gidley P, Morrison WH, et al. Treatment selection for carcinoma of the base of the tongue. Am J Surg. 1990;160(4):415-419.
9. Chen AY, Schrag N, Hao Y, Stewart A, Ward E. Changes in treatment of advanced oropharyngeal cancer, 1985-2001. Laryngoscope. 2007;117(1):16-21.
10. Parsons JT, Mendenhall WM, Stringer SP, et al. Squamous cell carcinoma of the oropharynx: surgery, radiation therapy, or both. Cancer. 2002;94(11):2967-2980.
11. Spiro RH. Hayes Marting Lecture: less can mean more. Am J Surg. 1993;166(4):322-325.
12. Steel P, Maran A. Conservation surgery. In: Watkinson JC, Gaze MN, Wilson JE, eds. Head and Neck Surgery. 4th ed. Woburn, MA: Butterworth Heinemann; 2000: 487-495.
13. Ambrosch P, Kron M, Freudenberg LS. Clinical staging of oropharyngeal carcinoma: a critical evaluation of a new stage grouping proposal. Cancer. 1998;82(9):1613-1620.
14. Moore EJ, Henstrom DK, Olsen KD, Kasperbauer JL, McGree ME. Transoral resection of tonsillar squamous cell carcinoma. Laryngoscope. 2009;119(3):508-515.
15. American Joint Committee on Cancer. Cancer Staging Manual. 6th ed. New York, NY: Springer; 2002.
16. Candela FC, Kothari K, Shah JP. Patterns of cervical node metastases from squamous cell carcinoma of the oropharynx and hypopharynx. Head Neck. 1990;12(3):197-203.
17. Adelstein DJ. Oropharyngeal cancer: the role of chemotherapy. Curr Treat Options Oncol. 2003;4(1):3-13.
18. Browman GP, Hodson DI, Mackenzie RJ, Bestic N, Zuraw L; Cancer Care Ontario Practice Guideline Initiative Head and Neck Cancer Disease Site Group. Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: a systematic review of the published literature with subgroup analysis. Head Neck. 2001;23(7):579-589.
19. Calais G, Alfonsi M, Bardet E, et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst. 1999;91(24):2081-2086.
20. Pignon JP, Bourhis J, Domenge C, Designé L; MACH-NC Collaborative Group. Chemotherapy added to locoregional treatment for head and squamous-cell carcinoma: three meta-analyses of updated individual data. Lancet. 2000;355:949-955.
21. Zhen W, Karnell LH, Hoffman HT, Funk GF, Buatti JM, Menck HR. The National Cancer Data Base report on squamous cell carcinoma of the base of tongue. Head Neck. 2004;26(8):660-674.
22. Brunin F, Mosseri V, Jaulerry C, Point D, Cosset JM, Rodriguez J. Cancer of the base of the tongue: past and future. Head Neck. 1999;21(8):751-759.
23. Sessions DG, Lenox J, Spector GJ, Chao C, Chaudry OA. Analysis of treatment results for base of tongue cancer. Laryngoscope. 2003;113(7):1252-1261.
24. Cooper JS, Pajak TF, Forastiere AA, et al; Radiation Therapy Oncology Group 9501/Intergroup. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med. 2004;350(19):1937-1944.
25. Machtay M, Rosenthal DI, Hershock D, et al; Penn Cancer Center Clinical Trials Group. Organ preservation therapy using induction plus concurrent chemoradiation for advanced resectable oropharyngeal carcinoma: a University of Pennsylvania phase II trial. J Clin Oncol. 2002;20(19):3964-3971.
26. Hoffman HT, Karnell LH, Funk GF, Robinson RA, Menck HR. The National Cancer Data Base report on cancer of the head and neck. Arch Otolaryngol Head Neck Surg. 1998;124(9):951-962.
27. Shirazi HA, Sivanandan R, Goode R, et al. Advanced-staged tonsillar squamous carcinoma: organ preservation versus surgical management of the primary site. Head Neck. 2006;28(7):587-594.
28. Staar S, Rudat V, Stuetzer H, et al. Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy: results of a multicentric randomized German trial in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2001;50(5):1161-1171.
29. Watkinson JC, Owen C, Thompson S, Das Gupta AR, Glaholm J. Conservation surgery in the management of T1 and T2 oropharyngeal squamous cell carcinoma: the Birmingham UK experience. Clin Otolaryngol Allied Sci. 2002;27(6):541-548.
30. Thoné M, Karengera D, Siciliano S, Reychler H. Reconstruction of the mobile tongue malignant tumor excision: quality-of-life assessment in 19 patients [in French]. Rev Stomatol Chir Maxillofac. 2003;104(1):19-24.
31. Shin DM, Glisson BS, Khuri FR, et al. Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck. Cancer. 2002;95(2):322-330.
32. Holsinger FC, McWhorter AJ, Menard M, Garcia D, Laccourreye O. Transoral lateral oropharyngectomy for squamous cell carcinoma of the tonsillar region, I: technique, complications, and functional results. Arch Otolaryngol Head Neck Surg. 2005;131(7):583-591.
33. Spiro JD, Spiro RH. Carcinoma of the tonsillar fossa: an update. Arch Otolaryngol Head Neck Surg. 1989;115(10):1186-1189.